<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2017-05-10" version="168">
<accession>O00329</accession>
<accession>A6NCG0</accession>
<accession>G1FFP1</accession>
<accession>O15445</accession>
<accession>Q5SR49</accession>
<name>PK3CD_HUMAN</name>
<protein>
<recommendedName>
<fullName>Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform</fullName>
<shortName>PI3-kinase subunit delta</shortName>
<shortName>PI3K-delta</shortName>
<shortName>PI3Kdelta</shortName>
<shortName>PtdIns-3-kinase subunit delta</shortName>
<ecNumber>2.7.1.153</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta</fullName>
<shortName>PtdIns-3-kinase subunit p110-delta</shortName>
<shortName>p110delta</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PIK3CD</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="4330" last="4335">
<title>P110delta, a novel phosphoinositide 3-kinase in leukocytes.</title>
<authorList>
<person name="Vanhaesebroeck B.A.M."/>
<person name="Welham M.J."/>
<person name="Kotani K."/>
<person name="Stein R."/>
<person name="Warne P.H."/>
<person name="Zvelebil M.J."/>
<person name="Higashi K."/>
<person name="Volinia S."/>
<person name="Downward J."/>
<person name="Waterfield M.D."/>
</authorList>
<dbReference type="PubMed" id="9113989"/>
<dbReference type="DOI" id="10.1073/pnas.94.9.4330"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="submission" date="2003-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Vanhaesebroeck B.A.M."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION TO 675</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="19236" last="19241">
<title>p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes.</title>
<authorList>
<person name="Chantry D."/>
<person name="Vojtek A."/>
<person name="Kashishian A."/>
<person name="Holtzman D.A."/>
<person name="Wood C."/>
<person name="Gray P.W."/>
<person name="Cooper J.A."/>
<person name="Hoekstra M.F."/>
</authorList>
<dbReference type="PubMed" id="9235916"/>
<dbReference type="DOI" id="10.1074/jbc.272.31.19236"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2012" name="Oncogene" volume="31" first="3277" last="3286">
<title>p37delta is a new isoform of PI3K p110delta that increases cell proliferation and is overexpressed in tumors.</title>
<authorList>
<person name="Fransson S."/>
<person name="Uv A."/>
<person name="Eriksson H."/>
<person name="Andersson M.K."/>
<person name="Wettergren Y."/>
<person name="Bergo M."/>
<person name="Ejeskar K."/>
</authorList>
<dbReference type="PubMed" id="22020336"/>
<dbReference type="DOI" id="10.1038/onc.2011.492"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH HRAS</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Peripheral blood leukocyte</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-10" db="EMBL/GenBank/DDBJ databases">
<title>Variations in the human phosphoinositide-3-kinase p110 gene in children with primary B-cell immunodeficiency of unknown etiology.</title>
<authorList>
<person name="Jou S.-T."/>
<person name="Chien Y.-H."/>
<person name="Yang Y.-H."/>
<person name="Shyur S.-D."/>
<person name="Chou C.-C."/>
<person name="Chiang B.-L."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="1292" last="1302">
<title>Autophosphorylation of p110 delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo.</title>
<authorList>
<person name="Vanhaesebroeck B."/>
<person name="Higashi K."/>
<person name="Raven C."/>
<person name="Welham M."/>
<person name="Anderson S."/>
<person name="Brennan P."/>
<person name="Ward S.G."/>
<person name="Waterfield M.D."/>
</authorList>
<dbReference type="PubMed" id="10064595"/>
<dbReference type="DOI" id="10.1093/emboj/18.5.1292"/>
</citation>
<scope>PROTEIN SEQUENCE OF 1031-1040</scope>
<scope>PHOSPHORYLATION AT SER-1039</scope>
<scope>MUTAGENESIS OF ARG-894 AND SER-1039</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-524 AND SER-1039</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2010" name="Blood" volume="115" first="2203" last="2213">
<title>PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans.</title>
<authorList>
<person name="Soond D.R."/>
<person name="Bjorgo E."/>
<person name="Moltu K."/>
<person name="Dale V.Q."/>
<person name="Patton D.T."/>
<person name="Torgersen K.M."/>
<person name="Galleway F."/>
<person name="Twomey B."/>
<person name="Clark J."/>
<person name="Gaston J.S.H."/>
<person name="Tasken K."/>
<person name="Bunyard P."/>
<person name="Okkenhaug K."/>
</authorList>
<dbReference type="PubMed" id="20081091"/>
<dbReference type="DOI" id="10.1182/blood-2009-07-232330"/>
</citation>
<scope>FUNCTION IN T-CELLS</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Nat. Rev. Immunol." volume="7" first="191" last="201">
<title>PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?</title>
<authorList>
<person name="Rommel C."/>
<person name="Camps M."/>
<person name="Ji H."/>
</authorList>
<dbReference type="PubMed" id="17290298"/>
<dbReference type="DOI" id="10.1038/nri2036"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2011" name="Cell. Signal." volume="23" first="603" last="608">
<title>Phosphoinositide 3-kinase delta (PI3Kdelta) in leukocyte signaling and function.</title>
<authorList>
<person name="Fung-Leung W.-P."/>
</authorList>
<dbReference type="PubMed" id="20940048"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2010.10.002"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1039</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2013" name="Science" volume="342" first="866" last="871">
<title>Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage.</title>
<authorList>
<person name="Angulo I."/>
<person name="Vadas O."/>
<person name="Garcon F."/>
<person name="Banham-Hall E."/>
<person name="Plagnol V."/>
<person name="Leahy T.R."/>
<person name="Baxendale H."/>
<person name="Coulter T."/>
<person name="Curtis J."/>
<person name="Wu C."/>
<person name="Blake-Palmer K."/>
<person name="Perisic O."/>
<person name="Smyth D."/>
<person name="Maes M."/>
<person name="Fiddler C."/>
<person name="Juss J."/>
<person name="Cilliers D."/>
<person name="Markelj G."/>
<person name="Chandra A."/>
<person name="Farmer G."/>
<person name="Kielkowska A."/>
<person name="Clark J."/>
<person name="Kracker S."/>
<person name="Debre M."/>
<person name="Picard C."/>
<person name="Pellier I."/>
<person name="Jabado N."/>
<person name="Morris J.A."/>
<person name="Barcenas-Morales G."/>
<person name="Fischer A."/>
<person name="Stephens L."/>
<person name="Hawkins P."/>
<person name="Barrett J.C."/>
<person name="Abinun M."/>
<person name="Clatworthy M."/>
<person name="Durandy A."/>
<person name="Doffinger R."/>
<person name="Chilvers E.R."/>
<person name="Cant A.J."/>
<person name="Kumararatne D."/>
<person name="Okkenhaug K."/>
<person name="Williams R.L."/>
<person name="Condliffe A."/>
<person name="Nejentsev S."/>
</authorList>
<dbReference type="PubMed" id="24136356"/>
<dbReference type="DOI" id="10.1126/science.1243292"/>
</citation>
<scope>VARIANT APDS LYS-1021</scope>
<scope>CHARACTERIZATION OF VARIANT APDS LYS-1021</scope>
</reference>
<comment type="function">
<text evidence="14 15">Phosphoinositide-3-kinase (PI3K) that phosphorylates PftdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Mediates immune responses. Plays a role in B-cell development, proliferation, migration, and function. Required for B-cell receptor (BCR) signaling. Mediates B-cell proliferation response to anti-IgM, anti-CD40 and IL4 stimulation. Promotes cytokine production in response to TLR4 and TLR9. Required for antibody class switch mediated by TLR9. Involved in the antigen presentation function of B-cells. Involved in B-cell chemotaxis in response to CXCL13 and sphingosine 1-phosphate (S1P). Required for proliferation, signaling and cytokine production of naive, effector and memory T-cells. Required for T-cell receptor (TCR) signaling. Mediates TCR signaling events at the immune synapse. Activation by TCR leads to antigen-dependent memory T-cell migration and retention to antigenic tissues. Together with PIK3CG participates in T-cell development. Contributes to T-helper cell expansion and differentiation. Required for T-cell migration mediated by homing receptors SELL/CD62L, CCR7 and S1PR1 and antigen dependent recruitment of T-cells. Together with PIK3CG is involved in natural killer (NK) cell development and migration towards the sites of inflammation. Participates in NK cell receptor activation. Have a role in NK cell maturation and cytokine production. Together with PIK3CG is involved in neutrophil chemotaxis and extravasation. Together with PIK3CG participates in neutrophil respiratory burst. Have important roles in mast-cell development and mast cell mediated allergic response. Involved in stem cell factor (SCF)-mediated proliferation, adhesion and migration. Required for allergen-IgE-induced degranulation and cytokine release. The lipid kinase activity is required for its biological function. Isoform 2 may be involved in stabilizing total RAS levels, resulting in increased ERK phosphorylation and increased PI3K activity.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="14">Activated by growth factors and cytokine receptors through a tyrosine-kinase-dependent mechanism. Activated by RAS. IC87114 inhibits lipid kinase activity and is selective in cells at doses up to 5-10 uM. IC87114 blocks T-cell receptor signaling in naive and memory T-cells and reduces cytokine production by memory T-cells.</text>
</comment>
<comment type="pathway">
<text>Phospholipid metabolism; phosphatidylinositol phosphate biosynthesis.</text>
</comment>
<comment type="subunit">
<text evidence="6 15">Heterodimer of a catalytic subunit PIK3CD and a p85 regulatory subunit (PIK3R1, PIK3R2 or PIK3R3). Interacts with ERAS (By similarity). Interacts with HRAS.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-718309"/>
<interactant intactId="EBI-350145">
<id>P01112</id>
<label>HRAS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="15">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O00329-1</id>
<name>1</name>
<name>p110-delta</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O00329-2</id>
<name>2</name>
<name>p37-delta</name>
<sequence type="described" ref="VSP_044409 VSP_044410"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="15">Isoform 2 is expressed in normal thymus, lung and spleen tissues, and is detected at low levels in normal lysates from colon and ovarian biopsies, at elevated levels in lysates from colorectal tumors and is abundantly expressed in some ovarian tumors (at protein level). Both isoform 1 and isoform 2 are widely expressed. Isoform 1 is expressed predominantly in leukocytes.</text>
</comment>
<comment type="PTM">
<text evidence="13">Autophosphorylation on Ser-1039 results in the almost complete inactivation of the lipid kinase activity.</text>
</comment>
<comment type="disease" evidence="16">
<disease id="DI-03995">
<name>Activated PI3K-delta syndrome</name>
<acronym>APDS</acronym>
<description>A disorder characterized by recurrent respiratory infections, progressive airway damage, lymphopenia, increased circulating transitional B cells, increased immunoglobulin M, reduced immunoglobulin G2 levels in serum, and impaired vaccine responses.</description>
<dbReference type="MIM" id="615513"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>IC87114 inhibitor reduces passive cutaneous anaphylaxis, attenuates allergic airway inflammation and hyperresponsiveness and allergen induced rhinitis response. Inhibitors may have therapeutic potential for the treatment of immune system-mediated diseases such as auto-immune diseases, inflammation and allergy (PubMed:20940048; PubMed:17290298).</text>
</comment>
<comment type="similarity">
<text evidence="9 11 12">Belongs to the PI3/PI4-kinase family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PIK3CDID46261ch1p36.html"/>
</comment>
<dbReference type="EC" id="2.7.1.153"/>
<dbReference type="EMBL" id="Y10055">
<property type="protein sequence ID" value="CAA71149.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U86453">
<property type="protein sequence ID" value="AAC25677.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="JN190435">
<property type="protein sequence ID" value="AEK81610.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ263594">
<property type="protein sequence ID" value="ABB83814.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL691449">
<property type="protein sequence ID" value="CAI15703.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC132919">
<property type="protein sequence ID" value="AAI32920.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC132921">
<property type="protein sequence ID" value="AAI32922.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS104.1">
<molecule id="O00329-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005017.3">
<molecule id="O00329-1"/>
<property type="nucleotide sequence ID" value="NM_005026.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006710750.1">
<molecule id="O00329-1"/>
<property type="nucleotide sequence ID" value="XM_006710687.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006710752.1">
<molecule id="O00329-1"/>
<property type="nucleotide sequence ID" value="XM_006710689.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.518451"/>
<dbReference type="PDB" id="5DXU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="A=2-1044"/>
</dbReference>
<dbReference type="PDB" id="5M6U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A=17-1027"/>
</dbReference>
<dbReference type="PDB" id="5T8F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.91"/>
<property type="chains" value="A=17-1031"/>
</dbReference>
<dbReference type="PDB" id="5UBT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.83"/>
<property type="chains" value="A=17-1029"/>
</dbReference>
<dbReference type="PDBsum" id="5DXU"/>
<dbReference type="PDBsum" id="5M6U"/>
<dbReference type="PDBsum" id="5T8F"/>
<dbReference type="PDBsum" id="5UBT"/>
<dbReference type="ProteinModelPortal" id="O00329"/>
<dbReference type="SMR" id="O00329"/>
<dbReference type="BioGrid" id="111311">
<property type="interactions" value="10"/>
</dbReference>
<dbReference type="IntAct" id="O00329">
<property type="interactions" value="10"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000366563"/>
<dbReference type="BindingDB" id="O00329"/>
<dbReference type="ChEMBL" id="CHEMBL3130"/>
<dbReference type="DrugBank" id="DB06831">
<property type="generic name" value="2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE"/>
</dbReference>
<dbReference type="DrugBank" id="DB00201">
<property type="generic name" value="Caffeine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05241">
<property type="generic name" value="XL765"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2155"/>
<dbReference type="SwissLipids" id="SLP:000000908"/>
<dbReference type="iPTMnet" id="O00329"/>
<dbReference type="PhosphoSitePlus" id="O00329"/>
<dbReference type="BioMuta" id="PIK3CD"/>
<dbReference type="EPD" id="O00329"/>
<dbReference type="MaxQB" id="O00329"/>
<dbReference type="PaxDb" id="O00329"/>
<dbReference type="PeptideAtlas" id="O00329"/>
<dbReference type="PRIDE" id="O00329"/>
<dbReference type="DNASU" id="5293"/>
<dbReference type="Ensembl" id="ENST00000377346">
<molecule id="O00329-1"/>
<property type="protein sequence ID" value="ENSP00000366563"/>
<property type="gene ID" value="ENSG00000171608"/>
</dbReference>
<dbReference type="GeneID" id="5293"/>
<dbReference type="KEGG" id="hsa:5293"/>
<dbReference type="UCSC" id="uc001aqb.5">
<molecule id="O00329-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5293"/>
<dbReference type="DisGeNET" id="5293"/>
<dbReference type="GeneCards" id="PIK3CD"/>
<dbReference type="HGNC" id="HGNC:8977">
<property type="gene designation" value="PIK3CD"/>
</dbReference>
<dbReference type="HPA" id="CAB015420"/>
<dbReference type="HPA" id="HPA044953"/>
<dbReference type="MalaCards" id="PIK3CD"/>
<dbReference type="MIM" id="602839">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615513">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O00329"/>
<dbReference type="OpenTargets" id="ENSG00000171608"/>
<dbReference type="Orphanet" id="397596">
<property type="disease" value="Activated PIK3-delta syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33310"/>
<dbReference type="eggNOG" id="KOG0904">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5032">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119110"/>
<dbReference type="HOGENOM" id="HOG000252911"/>
<dbReference type="HOVERGEN" id="HBG052721"/>
<dbReference type="InParanoid" id="O00329"/>
<dbReference type="KO" id="K00922"/>
<dbReference type="PhylomeDB" id="O00329"/>
<dbReference type="TreeFam" id="TF102031"/>
<dbReference type="BioCyc" id="MetaCyc:ENSG00000171608-MONOMER"/>
<dbReference type="BRENDA" id="2.7.1.137">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="2.7.1.153">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-114604">
<property type="pathway name" value="GPVI-mediated activation cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660499">
<property type="pathway name" value="Synthesis of PIPs at the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-392451">
<property type="pathway name" value="G beta:gamma signalling through PI3Kgamma"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-512988">
<property type="pathway name" value="Interleukin-3, 5 and GM-CSF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853659">
<property type="pathway name" value="RET signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912526">
<property type="pathway name" value="Interleukin receptor SHC signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912631">
<property type="pathway name" value="Regulation of signaling by CBL"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983695">
<property type="pathway name" value="Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"/>
</dbReference>
<dbReference type="SignaLink" id="O00329"/>
<dbReference type="SIGNOR" id="O00329"/>
<dbReference type="UniPathway" id="UPA00220"/>
<dbReference type="ChiTaRS" id="PIK3CD">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="P110%CE%B4"/>
<dbReference type="GenomeRNAi" id="5293"/>
<dbReference type="PRO" id="PR:O00329"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000171608"/>
<dbReference type="CleanEx" id="HS_PIK3CD"/>
<dbReference type="ExpressionAtlas" id="O00329">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O00329">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042629">
<property type="term" value="C:mast cell granule"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0005942">
<property type="term" value="C:phosphatidylinositol 3-kinase complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016303">
<property type="term" value="F:1-phosphatidylinositol-3-kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035005">
<property type="term" value="F:1-phosphatidylinositol-4-phosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0035004">
<property type="term" value="F:phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042113">
<property type="term" value="P:B cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035754">
<property type="term" value="P:B cell chemotaxis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050853">
<property type="term" value="P:B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001816">
<property type="term" value="P:cytokine production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002551">
<property type="term" value="P:mast cell chemotaxis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043303">
<property type="term" value="P:mast cell degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060374">
<property type="term" value="P:mast cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030101">
<property type="term" value="P:natural killer cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035747">
<property type="term" value="P:natural killer cell chemotaxis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001779">
<property type="term" value="P:natural killer cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030593">
<property type="term" value="P:neutrophil chemotaxis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072672">
<property type="term" value="P:neutrophil extravasation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014065">
<property type="term" value="P:phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006661">
<property type="term" value="P:phosphatidylinositol biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016310">
<property type="term" value="P:phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0033031">
<property type="term" value="P:positive regulation of neutrophil apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014066">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002679">
<property type="term" value="P:respiratory burst involved in defense response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042110">
<property type="term" value="P:T cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010818">
<property type="term" value="P:T cell chemotaxis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030217">
<property type="term" value="P:T cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.1070.11">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.150">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR016024">
<property type="entry name" value="ARM-type_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR000008">
<property type="entry name" value="C2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000403">
<property type="entry name" value="PI3/4_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR018936">
<property type="entry name" value="PI3/4_kinase_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR003113">
<property type="entry name" value="PI3K_adapt-bd_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002420">
<property type="entry name" value="PI3K_C2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000341">
<property type="entry name" value="PI3K_Ras-bd_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR015433">
<property type="entry name" value="PI_Kinase"/>
</dbReference>
<dbReference type="InterPro" id="IPR001263">
<property type="entry name" value="PInositide-3_kin_accessory_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR029071">
<property type="entry name" value="Ubiquitin-rel_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10048">
<property type="entry name" value="PTHR10048"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00454">
<property type="entry name" value="PI3_PI4_kinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00792">
<property type="entry name" value="PI3K_C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02192">
<property type="entry name" value="PI3K_p85B"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00794">
<property type="entry name" value="PI3K_rbd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00613">
<property type="entry name" value="PI3Ka"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00142">
<property type="entry name" value="PI3K_C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00143">
<property type="entry name" value="PI3K_p85B"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00144">
<property type="entry name" value="PI3K_rbd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00145">
<property type="entry name" value="PI3Ka"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00146">
<property type="entry name" value="PI3Kc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48371">
<property type="entry name" value="SSF48371"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49562">
<property type="entry name" value="SSF49562"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54236">
<property type="entry name" value="SSF54236"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00915">
<property type="entry name" value="PI3_4_KINASE_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00916">
<property type="entry name" value="PI3_4_KINASE_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50290">
<property type="entry name" value="PI3_4_KINASE_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51544">
<property type="entry name" value="PI3K_ABD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51547">
<property type="entry name" value="PI3K_C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51546">
<property type="entry name" value="PI3K_RBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51545">
<property type="entry name" value="PIK_HELICAL"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0145">Chemotaxis</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform" id="PRO_0000088790">
<location>
<begin position="1"/>
<end position="1044"/>
</location>
</feature>
<feature type="domain" description="PI3K-ABD" evidence="9">
<location>
<begin position="16"/>
<end position="105"/>
</location>
</feature>
<feature type="domain" description="PI3K-RBD" evidence="11">
<location>
<begin position="187"/>
<end position="278"/>
</location>
</feature>
<feature type="domain" description="C2 PI3K-type" evidence="12">
<location>
<begin position="319"/>
<end position="476"/>
</location>
</feature>
<feature type="domain" description="PIK helical" evidence="10">
<location>
<begin position="497"/>
<end position="674"/>
</location>
</feature>
<feature type="domain" description="PI3K/PI4K" evidence="8">
<location>
<begin position="774"/>
<end position="1041"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="315"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="4">
<location>
<position position="524"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="4 5 13">
<location>
<position position="1039"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044409" evidence="17">
<original>ESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPR</original>
<variation>VSPCVACGIQAALSMGSTSSVKLLSHPQAPLPQWHQMVFARCLCMCGAQLNVPPGELHLPGVHQGRAAGADGLCPAEEGHSVPAAAGGAAGRLHAAGERQ</variation>
<location>
<begin position="201"/>
<end position="300"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044410" evidence="17">
<location>
<begin position="302"/>
<end position="1044"/>
</location>
</feature>
<feature type="sequence variant" description="In APDS; results in gain of function causing enhanced membrane association and kinase activity; dbSNP:rs397518423." id="VAR_070918" evidence="16">
<original>E</original>
<variation>K</variation>
<location>
<position position="1021"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes lipid and protein kinase activities." evidence="13">
<original>R</original>
<variation>P</variation>
<location>
<position position="894"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autophosphorylation, no effect on lipid kinase activity." evidence="13">
<original>S</original>
<variation>A</variation>
<location>
<position position="1039"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autophosphorylation, reduced lipid kinase activity." evidence="13">
<original>S</original>
<variation>D</variation>
<variation>E</variation>
<location>
<position position="1039"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC25677." ref="3" evidence="18">
<original>S</original>
<variation>N</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="19"/>
<end position="25"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="31"/>
<end position="37"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="42"/>
<end position="53"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="59"/>
<end position="61"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="65"/>
<end position="67"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="68"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="79"/>
<end position="82"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="89"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="94"/>
<end position="104"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="108"/>
<end position="121"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="126"/>
<end position="130"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="134"/>
<end position="156"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="159"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="192"/>
<end position="196"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="203"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="213"/>
<end position="221"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="236"/>
<end position="238"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="239"/>
<end position="243"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="248"/>
<end position="250"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="252"/>
<end position="254"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="256"/>
<end position="258"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="260"/>
<end position="268"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="273"/>
<end position="278"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="279"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="321"/>
<end position="332"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="339"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="352"/>
<end position="355"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="370"/>
<end position="380"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="381"/>
<end position="383"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="389"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="416"/>
<end position="426"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="430"/>
<end position="432"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="435"/>
<end position="440"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="465"/>
<end position="467"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="470"/>
<end position="475"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="479"/>
<end position="481"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="488"/>
<end position="491"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="492"/>
<end position="495"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="506"/>
<end position="515"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="517"/>
<end position="519"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="525"/>
<end position="533"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="535"/>
<end position="541"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="543"/>
<end position="545"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="546"/>
<end position="552"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="558"/>
<end position="569"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="576"/>
<end position="582"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="590"/>
<end position="600"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="605"/>
<end position="610"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="612"/>
<end position="618"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="619"/>
<end position="621"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="623"/>
<end position="626"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="628"/>
<end position="639"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="641"/>
<end position="652"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="653"/>
<end position="656"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="658"/>
<end position="673"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="676"/>
<end position="705"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="708"/>
<end position="720"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="722"/>
<end position="728"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="729"/>
<end position="732"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="739"/>
<end position="741"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="746"/>
<end position="748"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="754"/>
<end position="756"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="759"/>
<end position="764"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="775"/>
<end position="782"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="785"/>
<end position="802"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="803"/>
<end position="805"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="815"/>
<end position="819"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="822"/>
<end position="826"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="829"/>
<end position="833"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="834"/>
<end position="839"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="854"/>
<end position="862"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="865"/>
<end position="867"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="868"/>
<end position="888"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="898"/>
<end position="902"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="907"/>
<end position="909"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="936"/>
<end position="942"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="943"/>
<end position="945"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="950"/>
<end position="969"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="971"/>
<end position="981"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="982"/>
<end position="984"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="992"/>
<end position="1001"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1002"/>
<end position="1005"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1008"/>
<end position="1030"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5DXU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5M6U"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UBT"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8BTI9"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00269"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00877"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00878"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00879"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00880"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10064595"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20081091"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22020336"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24136356"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="22020336"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000305"/>
<sequence length="1044" mass="119479" checksum="A38B5D1A1081A3D0" modified="2005-06-07" version="2">
MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFH
MLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLL
IGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGP
GTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYT
LQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPR
AKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSS
SEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAW
ANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAP
HPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQE
HFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSL
RKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSV
ALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMR
QEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKN
GDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLN
KSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIM
IRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYC
ERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFN
EALRESWKTKVNWLAHNVSKDNRQ
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>